Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism ferroptosis'

Search results for: 'research area metabolism ferroptosis'

Items 1-10 of 374

Page
per page
  1. Phenylalanine & tyrosine metabolism
    M1118 Phenylalanine & tyrosine metabolism
    Summary: A metabolic intermediate that can be synthesized into 3-phenyllactic acid via lactate dehydrogenase.
      ≥30.4 mg/mL
  2. GW9662
    A4300 GW9662
     7 Citation
    Summary: PPARγ antagonist
      insoluble in H2O; ≥13.75 mg/mL
  3. FK866 (APO866)
    A4381 FK866 (APO866)
     12 Citation
    Target: Nampt
    Summary: NAMPT inhibitor, non-competitive, highly specific
      insoluble in H2O; ≥19.6 mg/mL
  4. Rosiglitazone
    A4304 Rosiglitazone
     7 Citation
    Summary: Potent PPARγ agonist
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  5. Tributyrin
    A4638 Tributyrin
      ≥55.9 mg/mL
  6. Etofibrate
    B1753 Etofibrate
    Summary: Fibrate antihyperlipidemic agent
  7. Acetaminophen-d3
    SL1066 Acetaminophen-d3
    Summary: A stable isotope deuterated compound of Acetaminophen
  8. Xylose
    B2067 Xylose
    Summary: monosaccharide of the aldopentose type
      ≥113.8 mg/mL
  9. Clozapine-d8
    SL1037 Clozapine-d8
    Summary: A stable isotope deuterated compound of Clozapine
  10. Ribociclib-d6
    SL1064 Ribociclib-d6
    Summary: A stable isotope deuterated compound of Ribociclib

Items 1-10 of 374

Page
per page